Durham, NC, United States of America

Zoheb B Kazi

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Duke University. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zoheb B Kazi. Retrieved from https://idiyas.com/inventor/zoheb-b-kazi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Zoheb B Kazi

Introduction

Zoheb B Kazi is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of metabolic diseases through his innovative research and patenting efforts. His work focuses on improving treatment methods for patients undergoing protein replacement therapy.

Latest Patents

Zoheb B Kazi holds a patent titled "Methods for the use of low-dose immune modulators transiently for treating patients undergoing protein replacement therapy." This patent provides compositions and methods for inducing immune tolerance in subjects suffering from metabolic diseases. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Kazi is affiliated with Duke University, where he conducts research and collaborates with other experts in the field. His work at the university allows him to explore innovative solutions to complex medical challenges.

Collaborations

Some of his notable coworkers include Ankit K Desai and Priya Kishnani. Their collaborative efforts contribute to the advancement of research in metabolic diseases and related therapies.

Conclusion

Zoheb B Kazi's contributions to the field of metabolic diseases through his patent and research at Duke University highlight his role as an innovative inventor. His work continues to pave the way for new treatment methods that can significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…